Cargando…
Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer
Prostate cancer (PCa) is the most commonly diagnosed neoplasm and the second leading cause of cancer-related deaths in men. Acquisition of resistance to conventional therapy is a major problem for PCa patient management. Several mechanisms have been described to promote therapy resistance in PCa, su...
Autores principales: | Pinto, Filipe, Pértega-Gomes, Nelma, Vizcaíno, José R., Andrade, Raquel P., Cárcano, Flavio M., Reis, Rui Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045364/ https://www.ncbi.nlm.nih.gov/pubmed/27049720 http://dx.doi.org/10.18632/oncotarget.8499 |
Ejemplares similares
-
Clinical impact of the metabolic phenotype of prostate cancer: role of monocarboxylate transporters (MCTs)
por: Pértega-Gomes, Nelma, et al.
Publicado: (2013) -
Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?
por: Pértega-Gomes, Nelma, et al.
Publicado: (2014) -
Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer
por: Valença, Isabel, et al.
Publicado: (2015) -
A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer
por: Pértega-Gomes, Nelma, et al.
Publicado: (2014) -
Brachyury identifies a class of enteroendocrine cells in normal human intestinal crypts and colorectal cancer
por: Jezkova, Jana, et al.
Publicado: (2016)